PAR 3.23% 30.0¢ paradigm biopharmaceuticals limited..

Breakthrough arthritis treatments will be available in five years, page-10

  1. 1,578 Posts.
    lightbulb Created with Sketch. 165
    Yes, well we all know regulatory approval will not
    happen before 2026-2027,IF everything goes
    according to plan; and nothing goes according
    to plan, especially with this company.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $108.4M
Open High Low Value Volume
31.0¢ 31.5¢ 30.0¢ $92.24K 296.4K

Buyers (Bids)

No. Vol. Price($)
4 13427 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 6472 3
View Market Depth
Last trade - 11.30am 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.